Gilead Gets Hep C Drug Patent Suit Shipped To Calif.
Gilead Sciences won its bid to transfer a patent infringement suit filed by the University of Minnesota over the company's blockbuster hepatitis C drugs to California on Friday when a Minnesota...To view the full article, register now.
Already a subscriber? Click here to view full article